[Therapy for metabolic syndrome].
Node
Koichi
K
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control; D004038:Diet, Reducing; D004730:Endothelium, Vascular / Q000503:physiopathology; D005081:Exercise Therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007333:Insulin Resistance; D008077:Lipoproteins, LDL / Q000378:metabolism; D024821:Metabolic Syndrome / Q000150:complications / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*
D047228:Angiotensin II Type 1 Receptor Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein